Lv3
398 积分 2022-10-24 加入
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma
2小时前
待确认
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
2个月前
已完结
Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager
9个月前
已完结
Harnessing T cells to fight cancer with BiTE® antibody constructs – past developments and future directions
9个月前
已完结
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
10个月前
已完结
Enhancement of Antitumor Immunity by CTLA-4 Blockade
10个月前
已完结
BCMAxCD3 Bispecific Yields Robust Responses in Myeloma
1年前
已完结
Abstract 4551: Preclinical characterization of novel anti-CTLA-4 prodrug antibodies with an enhanced therapeutic index
1年前
已关闭
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment
1年前
已完结
探讨导致器官移植排斥的免疫学原因
1年前
已完结
皖公网安备34019202002308
